Navigation Links
Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/3/2010

curities, available-for-sale

92,23354,500Prepaid expenses and other current assets

1,8501,529Total current assets

102,45593,687Property and equipment, net

9901,324Restricted cash

8811,290Other assets

299547Total assets

$
4,625$
96,848Liabilities and stockholders' equity Current liabilities:Accounts payable and accrued expenses

$
,885$
9,828Deferred revenue, current portion

3,51788Long-term debt, current portion

3,7416,384Total current liabilities

14,14316,300Deferred revenue, less current portion

47,190971Long-term debt, less current portion

-2,416Other long-term liabilities

4901,258Commitments and contingenciesStockholders’ equity:Preferred stock, $.001 par value, 10,000,000 shares authorized at September 30, 2010 and December 31, 2009; noshares issued and outstanding at  September 30, 2010 and December 31, 2009

--Common stock, $.001 par value, 100,000,000 sharesauthorized at September 30, 2010 and December 31, 2009;47,556,739 and 47,215,479 shares issued and outstanding at September 30, 2010 and December 31, 2009, respectively

4847Additional paid-in capital

350,115342,599Accumulated other comprehensive income (loss)

4(6)Deficit accumulated during the development stage

(307,365)(266,737)Total stockholders’ equity

42,80275,903Total liabilities and stockholders’ equity

$
4,625$
96,848Orexigen Therapeutics, Inc.(a development stage company)Statements of Operations(In thousands, except per share amounts)(Unaudited) Period fromThree Months Ended Nine Months Ended September 12, 2002September 30, September 30, (Inception) to 2010200920102009September 30, 2010Revenues:Collaborative agreement $286$-$286$-$

460License revenue 22226666507Total revenues 3082235266967Operating expenses:Research and development 8,1869,59221,75338,579238,312General and administrative 6,
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
2. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
3. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
4. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
5. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
6. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
7. Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity
8. Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders
9. Talecris Biotherapeutics Launches PROLASTIN®-C in Canada
10. Cell Therapeutics Awarded $977,917 in Grants Under the Therapeutic Discovery Tax Credit Program
11. Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a ... that Thomas M. Patton , President and ... Annual Marcum MicroCap Conference on Thursday, May 30, 2013, at ... . The presentation is scheduled to begin ... will be available via a live webcast at http://wsw.com/webcast/marcum/casm/ ...
(Date:5/23/2013)... 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... on the development and commercialization of novel bile acid ... biliary cirrhosis, today announced that Mark Pruzanski ... present at the Deutsche Bank Securities 38th Annual Health ... Wednesday, May 29, 2013 at 4:10 p.m. ET. ...
(Date:5/23/2013)... CARLSBAD, Calif. , May 23, 2013 Isis ... antisense therapeutics, today announced that management will present a company ... Health Care Conference on Thursday, May 30, 2013 at 8:40 ... A live audio webcast of the presentation will be ... Web site, www.isispharm.com .  A replay will be available ...
Breaking Medicine Technology:CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2
... Company (NYSE: ADM ) is pleased to ... effects of soy isoflavones in the alleviation of menopausal ... by Menopause: The Journal of The North American ... soy isoflavone supplements, like NovaSoy brand soy isoflavones, are ...
... /PRNewswire-iReach/ -- Global BioClinical (GBC) the Seattle-based contract ... a new website at www.globalbioclinical.com . The ... offered, partner registration, new search capabilities, and links ... The service descriptions function as a benchmark ...
Cached Medicine Technology:Study Confirms Soy Isoflavones Reduce Menopausal Hot Flashes 2Study Confirms Soy Isoflavones Reduce Menopausal Hot Flashes 3Global BioClinical Launches New Website 2
(Date:5/23/2013)... Camden, New Jersey (PRWEB) May 23, 2013 ... million Americans suffering from irritable bowel syndrome (IBS), the ... damper on your holiday fun. , “While hot dogs ... picnic plate during the warm weather months, IBS sufferers ... foods,” says Deborah Sokol, MD, a gastroenterologist with Lourdes ...
(Date:5/23/2013)... City, UT (PRWEB) May 23, 2013 ... , a comprehensive radiology learning environment for all ... prebuilt lessons and assessments, transforms the learning experience ... radiology curriculum. , “Until RADPrimer 3.0, ... second to none,” comments Dr. B.J. Manaster, Professor ...
(Date:5/23/2013)... (May 23, 2013)Don,t doubt it when a woman harried ... remembering things. A new study published online in ... Society (NAMS), helps confirm with objective tests that what ... In the past, some studies showed that hot flashes ... studies showed that, even though there was a relationship ...
(Date:5/23/2013)... being dragged to its destruction inside a cell, ... signals that thwart the development of tumor-suppressing microRNAs ... early online publication at Nature . , ... tumors, the epidermal growth factor receptor (EGFR) gums ... led by scientists at The University of Texas ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Transvaginal ... Bard, Inc., continue to move forward in a federal ... of West Virginia, Bernstein Liebhard LLP reports. In ... a request by C.R. Bard to seal emails that ... secrets and other confidential, proprietary information about its suppliers. ...
Breaking Medicine News(10 mins):Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 2Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 3Health News:RADPrimer 3.0 Introduces Comprehensive Radiology Training Curriculum 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3
... of Knowledge Award in the Biomedicine category goes in ... New York, United States), investigator in the Department of ... granted, in the words of the jury, "for his ... the largest, most versatile and most therapeutically accessible receptor ...
... research , WEDNESDAY, Jan. 27 (HealthDay News) -- Same-sex couples ... couples are, a review of 20 years of social science ... out there that children need both a mother and a ... professor of sociology and of social and cultural analysis at ...
... ... ... 27, 2010 -- Epocrates, Inc. and RealCME announced today ... an advanced technology platform that addresses the needs of CME providers, supporters and health ...
... ... and 104E industrial computers.,Percon rejoins the AIDC and industrial computer industries with their release of ... data terminals or fixed mount computers are designed to operate in the harshest of environments. ... (PRWEB) January 27, ...
... Interest in whether ... New York, medical malpractice attorneys say. , ... New York, NY (PRWEB) January 27, 2010 -- Medical professionals of any kind ... standards of practice in the medical community. Unfortunately, a number of issues may compromise this ...
... ... with over 30 years combined experience in the hospitality industry. Their knowledge of writing ... Hakuna combines the mind of a manger with the speed and processing power of ... (PRWEB) January ...
Cached Medicine News:Health News:Lefkowitz, BBVA Foundation Frontiers of Knowledge Award in Biomedicine 2Health News:Lefkowitz, BBVA Foundation Frontiers of Knowledge Award in Biomedicine 3Health News:Are Two Mommies as Good as Mom and Dad? 2Health News:Are Two Mommies as Good as Mom and Dad? 3Health News:Are Two Mommies as Good as Mom and Dad? 4Health News:Epocrates and RealCME Unite to Deliver Enhanced e-Learning Offerings 2Health News:Epocrates and RealCME Unite to Deliver Enhanced e-Learning Offerings 3Health News:Percon Delivers Maximum Value in New Industrial Vehicle Computer Products 2Health News:Tired Doctors Need More Rest According to New York Medical Malpractice Attorney, David Perecman 2Health News:Tired Doctors Need More Rest According to New York Medical Malpractice Attorney, David Perecman 3Health News:Hakuna Staff Scheduling Software is Proud To Announce the Launch of Its Online Employee Scheduling Program 2
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... a 1-step, hand-held, point-of-care device for the qualitative ... urine. The TOX/See device can detect up ... in 3 to 8 minutes and requires only ... is individually packaged to maximize convenience and ease ...
... Sugar-Chex Linearity is a whole blood ... reportable range of the most popular ... recommendations of using a control matrix ... Linearity is packaged in ready-to-use dropper ...
Medicine Products: